DermTech, Inc. (DMTK)
Total Valuation
DermTech has a market cap or net worth of $107.20 million. The enterprise value is $37.02 million.
| Market Cap | 107.20M |
| Enterprise Value | 37.02M |
Important Dates
The next earnings date is Tuesday, May 2, 2023, after market close.
| Estimated Earnings Date | May 2, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
DermTech has 30.37 million shares outstanding. The number of shares has increased by 4.00% in one year.
| Shares Outstanding | 30.37M |
| Shares Change (YoY) | +4.00% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 8.15% |
| Owned by Institutions (%) | 28.18% |
| Float | 26.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.63 |
| Forward PS | 2.40 |
| PB Ratio | 0.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.70, with a Debt / Equity ratio of 0.42.
| Current Ratio | 8.70 |
| Quick Ratio | 8.56 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -69.70% and return on invested capital (ROIC) is -100.40%.
| Return on Equity (ROE) | -69.70% |
| Return on Assets (ROA) | -54.80% |
| Return on Capital (ROIC) | -100.40% |
| Revenue Per Employee | $56,933 |
| Profits Per Employee | -$457,580 |
| Employee Count | 255 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 12.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.67% in the last 52 weeks. The beta is 2.58, so DermTech's price volatility has been higher than the market average.
| Beta (1Y) | 2.58 |
| 52-Week Price Change | -75.67% |
| 50-Day Moving Average | 4.45 |
| 200-Day Moving Average | 4.42 |
| Average Volume (30 Days) | 738,021 |
Short Selling Information
The latest short interest is 3.20 million, so 10.54% of the outstanding shares have been sold short.
| Short Interest | 3.20M |
| Short Previous Month | 3.12M |
| Short % of Shares Out | 10.54% |
| Short % of Float | 12.04% |
| Short Ratio (days to cover) | 6.44 |
Income Statement
In the last 12 months, DermTech had revenue of $14.52 million and -$116.68 million in losses. Loss per share was -$3.88.
| Revenue | 14.52M |
| Gross Profit | 647,000 |
| Operating Income | -118.17M |
| Pretax Income | -116.68M |
| Net Income | -116.68M |
| EBITDA | -112.22M |
| EBIT | -116.68M |
| Loss Per Share | -$3.88 |
Balance Sheet
The company has $129.66 million in cash and $55.83 million in debt, giving a net cash position of $73.83 million or $2.43 per share.
| Cash & Cash Equivalents | 129.66M |
| Total Debt | 55.83M |
| Net Cash | 73.83M |
| Net Cash Per Share | $2.43 |
| Equity / Book Value | 132.35M |
| Book Value Per Share | 4.36 |
| Working Capital | 120.40M |
Cash Flow
In the last 12 months, operating cash flow was -$95.26 million and capital expenditures -$3.31 million, giving a free cash flow of -$98.57 million.
| Operating Cash Flow | -95.26M |
| Capital Expenditures | -3.31M |
| Free Cash Flow | -98.57M |
| FCF Per Share | -$3.28 |
Margins
Gross margin is 4.46%, with operating and profit margins of -813.92% and -803.71%.
| Gross Margin | 4.46% |
| Operating Margin | -813.92% |
| Pretax Margin | -803.71% |
| Profit Margin | -803.71% |
| EBITDA Margin | -772.99% |
| EBIT Margin | -803.71% |
| FCF Margin | -678.92% |
Dividends & Yields
DermTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -105.27% |
| FCF Yield | -88.93% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.00% |
| Shareholder Yield | -4.00% |
Analyst Forecast
The average price target for DermTech is $7.48, which is 112.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.48 |
| Price Target Difference | 112.20% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 30, 2019. It was a reverse split with a ratio of 1:2.
| Last Split Date | Aug 30, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:2 |